Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-13 5:04 pm Purchase | 13G | EMERGENT BIOSOLUTIONS INC EBS | VANGUARD GROUP INC | 2,974,638 5.73% | 328,272 (+12.40%) | View |
2024-02-09 6:19 pm Purchase | 13G | EMERGENT BIOSOLUTIONS INC EBS | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,873,984 5.54% | 2,873,984 (New Position) | View |
2024-01-23 10:52 am Sale | 13G | EMERGENT BIOSOLUTIONS INC EBS | STATE STREET CORP STT | 1,062,951 2.05% | -69,004 (-6.10%) | View |
2024-01-19 2:40 pm Purchase | 13G | EMERGENT BIOSOLUTIONS INC EBS | BlackRock Inc. BLK | 9,399,197 18.1% | 17,305 (+0.18%) | View |
2024-01-18 4:16 pm Sale | 13G | EMERGENT BIOSOLUTIONS INC EBS | MILLENNIUM MANAGEMENT LLC | 2,095,662 4% | -615,737 (-22.71%) | View |
2023-11-07 3:33 pm Purchase | 13G | EMERGENT BIOSOLUTIONS INC EBS | BlackRock Inc. BLK | 9,381,892 18.1% | 2,981,689 (+46.59%) | View |
2023-10-10 11:27 am Sale | 13G | EMERGENT BIOSOLUTIONS INC EBS | STATE STREET CORP STT | 1,131,955 2.18% | -4,686,000 (-80.54%) | View |
2023-10-10 11:07 am Sale | 13G | EMERGENT BIOSOLUTIONS INC EBS | VANGUARD GROUP INC | 2,646,366 5.11% | -2,759,908 (-51.05%) | View |
2023-09-07 4:18 pm Purchase | 13G | EMERGENT BIOSOLUTIONS INC EBS | MILLENNIUM MANAGEMENT LLC | 2,711,399 5.2% | 2,711,399 (New Position) | View |
2023-09-07 09:38 am Sale | 13G | EMERGENT BIOSOLUTIONS INC EBS | BlackRock Inc. BLK | 6,400,203 12.4% | -2,555,015 (-28.53%) | View |
2023-02-09 11:19 am Purchase | 13G | EMERGENT BIOSOLUTIONS INC EBS | VANGUARD GROUP INC | 5,406,274 10.84% | 53,322 (+1.00%) | View |
2023-01-26 08:43 am Unchanged | 13G | EMERGENT BIOSOLUTIONS INC EBS | BlackRock Inc. BLK | 8,955,218 18% | 0 (Unchanged) | View |
2023-01-20 3:00 pm Purchase | 13G | EMERGENT BIOSOLUTIONS INC EBS | BlackRock Inc. BLK | 8,955,218 18% | 878,317 (+10.87%) | View |
2023-01-10 08:13 am Purchase | 13G | EMERGENT BIOSOLUTIONS INC EBS | STATE STREET CORP STT | 5,817,955 11.66% | 2,785,228 (+91.84%) | View |
2022-03-09 08:44 am Sale | 13G | EMERGENT BIOSOLUTIONS INC EBS | VANGUARD GROUP INC | 5,352,952 10.6% | -9,079 (-0.17%) | View |
2022-02-11 3:59 pm Sale | 13G | EMERGENT BIOSOLUTIONS INC EBS | Neuberger Berman Group LLC | 646,395 1.2% | -2,564,954 (-79.87%) | View |
2022-02-10 1:58 pm Purchase | 13G | EMERGENT BIOSOLUTIONS INC EBS | STATE STREET CORP STT | 3,032,727 5.64% | 3,032,727 (New Position) | View |
2022-02-10 08:11 am Sale | 13G | EMERGENT BIOSOLUTIONS INC EBS | VANGUARD GROUP INC | 5,362,031 9.97% | -54,813 (-1.01%) | View |
2022-01-27 5:13 pm Unchanged | 13G | EMERGENT BIOSOLUTIONS INC EBS | BlackRock Inc. BLK | 8,076,901 15% | 0 (Unchanged) | View |
2022-01-26 09:16 am Purchase | 13G | EMERGENT BIOSOLUTIONS INC EBS | BlackRock Inc. BLK | 8,076,901 15% | 2,713,394 (+50.59%) | View |